Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | +2.60% | -4.24% | +3.27% |
Apr. 22 | Transcript : Lexicon Pharmaceuticals, Inc. - Analyst/Investor Day | |
Mar. 25 | Lexicon Pharmaceuticals Files Prospectus for Secondary Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.27% | 389M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Lexicon Pharmaceuticals Q4 Net Loss Widens, Revenue Rises; to Resubmit NDA for Sotagliflozin; Shares Jump